GlobeStar Therapeutics Corp: common shares outstanding

Name: GlobeStar Therapeutics Corp: common shares outstanding
Creator: GlobeStar Therapeutics Corp

Common shares outstanding for GlobeStar Therapeutics Corp. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All GlobeStar Therapeutics Corp financial histories

What this measure means

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Exact concept: us-gaap:CommonStockSharesOutstanding. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-09-30 to 2023-09-30. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Common shares outstanding in original reported units, latest-filed observation per period
Period start	Period end	Value	Unit	Filed	Source filing
At date	2023-09-30	996,119,530	shares	2024-01-19	10-K · 0001161697-24-000049
At date	2022-09-30	722,326,669	shares	2024-01-19	10-K · 0001161697-24-000049
At date	2021-09-30	561,495,726	shares	2023-01-09	10-K · 0001161697-23-000049
At date	2020-09-30	436,218,342	shares	2022-01-05	10-K · 0001161697-22-000027
At date	2019-09-30	170,467,283	shares	2020-12-03	10-K · 0001161697-20-000517
At date	2018-09-30	69,323,021	shares	2019-12-31	10-K · 0001185185-19-001771
At date	2017-09-30	45,584,067	shares	2019-01-03	10-K · 0001185185-19-000011
At date	2016-09-30	33,520,667	shares	2018-01-16	10-K · 0001161697-18-000046
At date	2015-09-30	8,793,418	shares	2016-01-22	10-K · 0001161697-16-000635
At date	2014-09-30	256,202	shares	2016-01-22	10-K · 0001161697-16-000635
At date	2013-09-30	10,863,730	shares	2014-01-23	10-K/A · 0001161697-14-000042
At date	2012-09-30	5,646,415	shares	2014-01-23	10-K/A · 0001161697-14-000042
At date	2011-09-30	600,000	shares	2013-03-07	10-K/A · 0001161697-13-000174
At date	2010-09-30	9,000,000	shares	2011-12-29	10-K · 0001161697-11-001128

Related financial histories

Inspect the source

Entity: GlobeStar Therapeutics Corp / CIK 0001502152
Captured: 2026-09-21T17:19:31.788Z
SEC response SHA-256: 6be36a03e8f75354b6b3cf653d7b4e1bb0d8a85378e8b575eedf967d0fac66f7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001502152.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))